Arax Advisory Partners’s Aemetis AMTX Stock Holding History

Arax Advisory Partners’s Portfolio AMTX Stock Details AMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-130	Closed	-$292	–	4094
2025 Q3	$292	Buy	+130	New	+$345	﹤0.01%	3419

Other funds holding AMTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Arax Advisory Partners's AMTX Position: Q4 2025 in Review

Arax Advisory Partners sold out of Aemetis (AMTX) in Q4 2025, closing a stake of 130 shares — an estimated $292 sold.

Arax Advisory Partners first reported a position in AMTX in Q3 2025 and held it in 1 quarter. The position peaked at $292 in Q3 2025. 69 funds tracked by Wall St. Rank hold AMTX as of Q4 2025.

Arax Advisory Partners reported no remaining Aemetis position as of Q4 2025 after selling out during the quarter.
Arax Advisory Partners sold 130 Aemetis shares in Q4 2025, an estimated $292.
Arax Advisory Partners first reported a position in Aemetis in Q3 2025 and held it in 1 quarter.
Arax Advisory Partners's Aemetis position peaked at $292 in Q3 2025.
69 funds tracked by Wall St. Rank held Aemetis as of Q4 2025.

Based on Arax Advisory Partners's 13F filing for Q4 2025, filed 13 Feb 2026.